|
ZNF592 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.897500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.729500E-02 |
| Normal-vs-Stage2 |
2.467000E-01 |
| Normal-vs-Stage3 |
6.961100E-03 |
| Normal-vs-Stage4 |
4.743800E-02 |
| Stage1-vs-Stage2 |
8.418800E-01 |
| Stage1-vs-Stage3 |
2.088600E-01 |
| Stage1-vs-Stage4 |
6.016400E-01 |
| Stage2-vs-Stage3 |
2.957600E-01 |
| Stage2-vs-Stage4 |
5.765800E-01 |
| Stage3-vs-Stage4 |
6.787800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.783900E-02 |
| Normal-vs-AfricanAmerican |
6.863800E-01 |
| Normal-vs-Asian |
3.641200E-01 |
| Caucasian-vs-AfricanAmerican |
3.242400E-01 |
| Caucasian-vs-Asian |
4.106000E-01 |
| AfricanAmerican-vs-Asian |
7.366800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.855600E-02 |
| Normal-vs-Female |
5.016200E-02 |
| Male-vs-Female |
6.742400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.179800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.924000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.015730E-02 |
| Normal-vs-Age(81-100Yrs) |
5.206100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.382000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.630560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.209400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.201600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.193800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.079000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.535700E-02 |
| Classical-VS-Follicular |
6.09489999999768E-05 |
| Classical-VS-Other |
1.291840E-01 |
| Classical-VS-Normal |
3.441000E-01 |
| Tall-VS-Follicular |
2.639400E-01 |
| Tall-VS-Other |
4.134000E-01 |
| Tall-VS-Normal |
2.006100E-02 |
| Follicular-VS-Other |
8.736200E-01 |
| Follicular-VS-Normal |
2.759900E-04 |
| Other-VS-Normal |
3.939700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.087780E-02 |
| Normal-vs-N1 |
2.086400E-02 |
| N0-vs-N1 |
5.997000E-01 |
|
|
